BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raza S, Rajak S, Upadhyay A, Tewari A, Anthony Sinha R. Current treatment paradigms and emerging therapies for NAFLD/NASH. Front Biosci (Landmark Ed) 2021;26:206-37. [PMID: 33049668 DOI: 10.2741/4892] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Yu S, Wang J, Zheng H, Wang R, Johnson N, Li T, Li P, Lin J, Li Y, Yan J, Zhang Y, Zhu Z, Ding X. Pathogenesis from Inflammation to Cancer in NASH-Derived HCC. J Hepatocell Carcinoma 2022;9:855-67. [PMID: 36051860 DOI: 10.2147/JHC.S377768] [Reference Citation Analysis]
2 Lv W, Tan X, Chen X, Hu T, Jiang J, Li Q, Chen X, Tan H, Qian B. D ‐Limonene for regulating metabolism‐associated fatty liver disease (MAFLD) and analysis of the TCM constitution: A protocol for an exploratory, randomized, double‐blind, placebo‐controlled trial (DL‐MAFLD‐TCM). Food Frontiers. [DOI: 10.1002/fft2.171] [Reference Citation Analysis]
3 Afridi F, Mittal A, Pyrsopoulos N. Trends in Mortality and Health Care Burden of Cirrhotic Decompensation in Hospitalized Patients: A Nationwide Analysis. J Clin Gastroenterol 2022. [PMID: 35862058 DOI: 10.1097/MCG.0000000000001734] [Reference Citation Analysis]
4 Mao D, Xu M, Jiang Q, Sun H, Sun F, Yang R, Chai Y, Li X, Li B, Li Y. A Single Nucleotide Mixture Enhances the Antitumor Activity of Molecular-Targeted Drugs Against Hepatocellular Carcinoma. Front Pharmacol 2022;13:951831. [DOI: 10.3389/fphar.2022.951831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tang Q, Zeng M, Chen L, Fu N. Targeting Thyroid Hormone/Thyroid Hormone Receptor Axis: An Attractive Therapy Strategy in Liver Diseases. Front Pharmacol 2022;13:871100. [PMID: 35721201 DOI: 10.3389/fphar.2022.871100] [Reference Citation Analysis]
6 Passos E, Pereira C, Gonçalves IO, Faria A, Ascensão A, Monteiro R, Magalhães J, Martins MJ. Physical exercise positively modulates nonalcoholic steatohepatitis-related hepatic endoplasmic reticulum stress. J Cell Biochem 2022. [PMID: 35467032 DOI: 10.1002/jcb.30250] [Reference Citation Analysis]
7 Gao Z, Dai L, Zhang H, Cheng L. Screening Potential Drugs for the Development of NAFLD Based on Drug Perturbation Gene Set. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/7606716] [Reference Citation Analysis]
8 Rajak S, Gupta P, Anjum B, Raza S, Tewari A, Ghosh S, Tripathi M, Singh BK, Sinha RA. Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse. Biochim Biophys Acta Mol Basis Dis 2021;:166319. [PMID: 34954342 DOI: 10.1016/j.bbadis.2021.166319] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Mirashrafi S, Kafeshani M, Hassanzadeh A, Entezari MH. Is any association between alternate healthy eating index (AHEI) with lipid profile and liver enzymes? A cross-sectional Study. J Diabetes Metab Disord 2021;20:1537-44. [PMID: 34900806 DOI: 10.1007/s40200-021-00898-w] [Reference Citation Analysis]
10 Raza S, Tewari A, Rajak S, Sinha RA. Vitamins and non-alcoholic fatty liver disease: A Molecular Insight. Liver Res 2021;5:62-71. [PMID: 34221537 DOI: 10.1016/j.livres.2021.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Huang YL, Shen ZQ, Huang CH, Teng YC, Lin CH, Tsai TF. Cisd2 Protects the Liver from Oxidative Stress and Ameliorates Western Diet-Induced Nonalcoholic Fatty Liver Disease. Antioxidants (Basel) 2021;10:559. [PMID: 33916843 DOI: 10.3390/antiox10040559] [Reference Citation Analysis]
12 Gámez-Belmonte R, Tena-Garitaonaindia M, Hernández-Chirlaque C, Córdova S, Ceacero-Heras D, de Medina FS, Martínez-Augustin O. Deficiency in Tissue Non-Specific Alkaline Phosphatase Leads to Steatohepatitis in Mice Fed a High Fat Diet Similar to That Produced by a Methionine and Choline Deficient Diet. Int J Mol Sci 2020;22:E51. [PMID: 33374541 DOI: 10.3390/ijms22010051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]